Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2010 1
2011 1
2012 3
2013 6
2014 5
2015 2
2016 1
2017 9
2018 11
2019 5
2020 14
2021 8
2022 8
2023 6
2024 6
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors.
Boumaza X, Bonneau B, Roos-Weil D, Pinnetti C, Rauer S, Nitsch L, Del Bello A, Jelcic I, Sühs KW, Gasnault J, Goreci Y, Grauer O, Gnanapavan S, Wicklein R, Lambert N, Perpoint T, Beudel M, Clifford D, Sommet A, Cortese I, Martin-Blondel G; Immunotherapy for PML Study Group. Boumaza X, et al. Among authors: gnanapavan s. Ann Neurol. 2023 Feb;93(2):257-270. doi: 10.1002/ana.26512. Epub 2022 Oct 17. Ann Neurol. 2023. PMID: 36151879 Free PMC article.
Neurofilaments in neurologic disease.
Mousele C, Holden D, Gnanapavan S. Mousele C, et al. Among authors: gnanapavan s. Adv Clin Chem. 2024;123:65-128. doi: 10.1016/bs.acc.2024.06.010. Epub 2024 Jul 8. Adv Clin Chem. 2024. PMID: 39181624 Review.
Can rheumatologists stop causing demyelinating disease?
Baker D, Hadjicharalambous C, Gnanapavan S, Giovannoni G. Baker D, et al. Among authors: gnanapavan s. Mult Scler Relat Disord. 2021 Aug;53:103057. doi: 10.1016/j.msard.2021.103057. Epub 2021 Jun 1. Mult Scler Relat Disord. 2021. PMID: 34126373 Review.
Cladribine tablets in relapsing-remitting multiple sclerosis preferentially target B-cells.
Ammoscato F, Wafa M, Skonieczna J, Bestwick J, Monero R, Andrews M, De Trane S, Holden D, Adams A, Bianchi L, Turner B, Marta M, Schmierer K, Baker D, Giovannoni G, Gnanapavan S. Ammoscato F, et al. Among authors: gnanapavan s. Clin Immunol. 2024 Dec;269:110380. doi: 10.1016/j.clim.2024.110380. Epub 2024 Oct 18. Clin Immunol. 2024. PMID: 39428028 Free article.
Positive cerebrospinal fluid in the 2024 McDonald criteria for multiple sclerosis.
Deisenhammer F, Hegen H, Arrambide G, Banwell BL, Coetzee T, Gnanapavan S, Montalban X, Tumani H, Willrich MA, Freedman MS. Deisenhammer F, et al. Among authors: gnanapavan s. EBioMedicine. 2025 Oct;120:105905. doi: 10.1016/j.ebiom.2025.105905. Epub 2025 Sep 17. EBioMedicine. 2025. PMID: 40967951 Free PMC article. Review.
Anaesthetic management of people with multiple sclerosis.
Dubuisson N, de Maere d'Aertrijcke O, Marta M, Gnanapavan S, Turner B, Baker D, Schmierer K, Giovannoni G, Verma V, Docquier MA. Dubuisson N, et al. Among authors: gnanapavan s. Mult Scler Relat Disord. 2023 Dec;80:105045. doi: 10.1016/j.msard.2023.105045. Epub 2023 Oct 11. Mult Scler Relat Disord. 2023. PMID: 37866022 Free article. Review.
Protecting people with multiple sclerosis through vaccination.
Reyes S, Ramsay M, Ladhani S, Amirthalingam G, Singh N, Cores C, Mathews J, Lambourne J, Marta M, Turner B, Gnanapavan S, Dobson R, Schmierer K, Giovannoni G. Reyes S, et al. Among authors: gnanapavan s. Pract Neurol. 2020 Dec;20(6):435-445. doi: 10.1136/practneurol-2020-002527. Epub 2020 Jul 6. Pract Neurol. 2020. PMID: 32632038 Review.
83 results